Semaglutide is generally very well tolerated with equivalent dropout premiums in comparison with placebo, even though it might be much less effectively tolerated than dulaglutide (Trulicity).one,3 The most typical adverse results are nausea, vomiting, and diarrhea and may be knowledgeable by about 30% of clients, usually once the dose is improved.K